Welcome to our dedicated page for FT Raymond James Multcp Gr Eq ETF news (Ticker: rjmg), a resource for investors and traders seeking the latest updates and insights on FT Raymond James Multcp Gr Eq ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FT Raymond James Multcp Gr Eq ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FT Raymond James Multcp Gr Eq ETF's position in the market.
First Trust (NYSE Arca: RJMG) approved a plan to liquidate the FT Raymond James Multicap Growth Equity ETF following the resignation of its sub‑advisor. Shareholders may sell shares through the end of trading on January 9, 2026; the Fund will stop accepting creations/redemptions that day and is expected to liquidate on or around January 16, 2026.
Holders on the liquidation date will receive a cash redemption equal to NAV after payment of liabilities; shareholders generally will recognize a capital gain or loss. After January 9, the Fund may hold more cash and will likely deviate from its investment objective. First Trust Advisors reports approximately $299 billion AUM as of September 30, 2025.
Summary not available.